Endoron Medical
Yokne'am Illit, Israel· Est.
Innovative anchoring solutions that enable safer, broader use of transcatheter aortic and endovascular repairs.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $2.7M
AI Company Overview
Innovative anchoring solutions that enable safer, broader use of transcatheter aortic and endovascular repairs.
Cardiovascular
Technology Platform
Transcatheter endovascular anchoring using nitinol frames and balloon‑expanded staples for calcium‑independent fixation in TAVR and EVAR procedures.
Opportunities
Expanding TAVR indications to low‑calcium AR patients and improving EVAR graft fixation could unlock sizable market segments and attract acquisition interest.
Risk Factors
Regulatory approval timelines, demonstration of clinical superiority, and competition from established device manufacturers pose significant risks.
Competitive Landscape
Competitors include Medtronic, Edwards Lifesciences, and Gore Medical, but Endoron’s calcium‑independent anchoring differentiates its devices from existing valve and graft platforms.